Rodriguez-Luna, H., Khatib, A., Sharma, P., De Petris, G., Williams, J. W., Ortiz, J., … Vargas, H. E. (2004). Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1. Transplantation, 77(2), 190–194. https://doi.org/10.1097/01.tp.0000100481.14514.bb

Rodriguez-Luna, Hector, Amer Khatib, Pratima Sharma, Giovanni De Petris, James W. Williams, Jose Ortiz, Kathleen Hansen, et al. “Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1.” Transplantation 77, no. 2 (January 2004): 190–94. https://doi.org/10.1097/01.tp.0000100481.14514.bb.

Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, et al. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1. Transplantation. 2004 Jan;77(2):190–4.

Rodriguez-Luna, Hector, et al. “Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1.” Transplantation, vol. 77, no. 2, Ovid Technologies (Wolters Kluwer Health), Jan. 2004, pp. 190–94. Crossref, doi:10.1097/01.tp.0000100481.14514.bb.

Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, Hansen K, Mulligan D, Moss A, Douglas DD, Balan V, Rakela J, Vargas HE. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1. Transplantation. Ovid Technologies (Wolters Kluwer Health); 2004 Jan;77(2):190–194.